| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5823403 | Biochemical Pharmacology | 2014 | 11 Pages |
Abstract
MDGA inhibits activation of the LXRα and attenuated neutral lipid accumulation in HFD-induced fatty liver.
Keywords
ACCTR-FRETRIP140Rifampicin (PubChem CID: 5381226)T0901317SCD-1stearoyl-CoA desaturase-1SREBPLXRPGC-1αPPARHFDAMPKLBDHDLFASmTORAMP-activated protein kinaseacetyl-coenzyme A carboxylasemeso-Dihydroguaiaretic acidfatty acid synthaseNonalcoholic fatty liver disease (NAFLD)triglycerideligand binding domainHigh fat diethigh density lipoproteinmammalian target of rapamycinsterol regulatory element binding proteinliver X receptorreverse cholesterol transportPeroxisome proliferator activated receptorReceptor interacting protein 140
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Woo-Cheol Sim, Sora Park, Kang-Yo Lee, Young-Tae Je, Hu-Quan Yin, You-Jin Choi, Sang Hyun Sung, So-Jung Park, Hyun-Ju Park, Kye Jung Shin, Byung-Hoon Lee,